Workflow
瑞普生物(300119) - 2015年2月2日投资者关系活动记录表
RINGPURINGPU(SZ:300119)2022-12-07 09:02

Group 1: Industry Challenges - The poultry market has faced unprecedented difficulties due to H7N9 avian flu and food safety incidents, leading to a prolonged downturn in chicken consumption [2] - The pig farming sector experienced continuous losses throughout the year, with significant losses at the beginning of the year [3] - The animal health industry has seen a slow recovery in market conditions, resulting in a decline in company performance [3] Group 2: Organizational Adjustments - The company is implementing a "research-production-sales integration" strategy, establishing various development centers to respond to market changes and enhance industry development [3] - A new group control model focusing on "industry development centers," "profit centers," and "responsibility centers" is being adopted to improve organizational efficiency and core competitiveness [3] Group 3: Product Development - The company is developing a range of new livestock products, including vaccines for porcine infectious gastroenteritis and porcine epidemic diarrhea [3] - The animal vaccine expansion project is currently underway, with plans to launch several new products in 2015 [3]